K. Kasow

发表

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.

T. Merchant, M. Chintagumpala, A. Gajjar, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Kyle M. Hebert, B. George, V. Mathews, 2019, Blood advances.

Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25− Counterparts 1

R. Handgretinger, J. Riberdy, K. Kasow, 2004, The Journal of Immunology.

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

J. Fay, W. Wood, J. Maciejewski, 2018, Leukemia research.

Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients: a mixed methods analysis

S. Wheeler, M. Kelly, K. Kasow, 2022, Supportive Care in Cancer.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.

V. Brown, R. Gale, S. Gadalla, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quantitative bone mineral density assessment in malignant infantile osteopetrosis

S. Kaste, E. Horwitz, K. Kasow, 2007, Pediatric blood & cancer.

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE

S. Grupp, N. Ueno, R. Gale, 2013, Bone Marrow Transplantation.

SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity

A. Schulz, L. Notarangelo, U. Kornak, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

J. Wingard, T. Spitzer, B. Shaw, 2020, Blood advances.

Non-Hodgkin lymphoma in a child with neuroblastoma preceding autologous stem cell transplant.

M. LaQuaglia, J. P. Hunt, K. Kasow, 2012, Clinical lymphoma, myeloma & leukemia.

CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

G. Hale, K. Kasow, P. Eldridge, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ethical Decision Making About End-of-life Care Issues by Pediatric Oncologists in Economically Diverse Settings

Christopher L Church, J. Baker, M. Hester, 2015, Journal of pediatric hematology/oncology.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

W. Wood, M. Sorror, M. Aljurf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

1α,25-dihydroxyvitamin D3 (vitamin D3) catalyzes suppressive activity on human natural regulatory T cells, uniquely modulates cell cycle progression, and augments FOXP3.

J. Riberdy, K. Kasow, T. Leimig, 2011, Clinical immunology.

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis

M. Norkin, J. Wingard, J. Liesveld, 2020, Bone Marrow Transplantation.

Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients

Z. Gu, R. Hayden, R. Hayden, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study

L. Meacham, K. Syrjala, B. Shaw, 2022, JMIR research protocols.

Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation

W. Leung, G. Hale, K. Kasow, 2009, Pediatric transplantation.

Malignant infantile osteopetrosis & primary pulmonary hypertension: A new combination?

R. Handgretinger, E. Horwitz, D. Margolis, 2004, Pediatric blood & cancer.

This information is current as Counterparts − CD 25 + Repertoires with CD 4 Share Equally Complex and Comparable Regulatory T Cells + CD 25 + Human CD 4

R. Handgretinger, J. Riberdy, K. Kasow, 2004 .

Staphylococcus aureus Bloodstream Infection Due to Contaminated Hematopoietic Stem-Cell Graft

D. Weber, K. Kasow, Zachary Willis, 2018, Infection Control & Hospital Epidemiology.

B. George, V. Mathews, C. Dvorak, 2018, Blood advances.

Possible allogeneic graft-versus-tumor effect in childhood melanoma.

A. Pappo, R. Handgretinger, M. Krasin, 2003, Journal of pediatric hematology/oncology.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

A. King, G. Cuvelier, N. Bunin, 2015, American journal of hematology.

Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists’ practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study

Isaac A. Janson, K. Kasow, G. Guilcher, 2021, Pediatric blood & cancer.

Using fludarabine to reduce exposure to alkylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: results of a dose de-escalation trial.

Melody Benton, J. Kanter, M. Nieder, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D34 Hematopoietic Progenitor Cell Selection of one Marrow Grafts for Autologous Transplantation n Pediatric Patients

G. Hale, K. Kasow, P. Eldridge, 2007 .

Benefits and challenges with diagnosing chronic and late acute GvHD in children using the NIH consensus criteria.

J. Chewning, G. Cuvelier, D. Coulter, 2019, Blood.

Advances in pediatric hematopoietic stem cell transplantation

G. Hale, K. Kasow, R. Barfield, 2008, Cancer biology & therapy.

Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.

S. Shurtleff, D. Persons, J. Riberdy, 2011, Clinical immunology.

Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation.

A. Srinivasan, D. Srivastava, J. Panetta, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cyclooxygenase-2 inhibition to treat radiation-induced brain necrosis and edema.

R. Khan, M. Krasin, W. Leung, 2004, Journal of pediatric hematology/oncology.

Transplant Outcomes for Children with T-Cell Acute Lymphoblastic Leukemia in Second Remission: A Report of the CIBMTR®

V. Brown, M. Cairo, M. Ayas, 2015 .

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

J. Szer, D. Stroncek, J. Liesveld, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plastic bronchitis: Autopsy findings in the sudden death of a healthy pediatric patient with sickle cell disease

L. Thorne, K. Kasow, V. Moylan, 2022, Pediatric blood & cancer.

Rapid immune reconstitution after a reduced‐intensity conditioning regimen and a CD3‐depleted haploidentical stem cell graft for paediatric refractory haematological malignancies

S. Shurtleff, F. Behm, D. Srivastava, 2006, British journal of haematology.

Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.

Allen R. Chen, S. Meshinchi, M. Loken, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical gene-marking of mesenchymal cells.

E. Horwitz, T. Hofmann, K. Kasow, 2003, Cytotherapy.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

J. Varni, W. Tse, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

P. Hari, J. Varni, W. Tse, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Phase I/II Study of Cyclophosphamide and Topotecan in Patients with High-Risk Malignancies Undergoing Autologous Hematopoietic Cell Transplantation: The St. Jude Long-term Follow-up

D. Srivastava, R. Handgretinger, E. Horwitz, 2016 .

EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation

R. Handgretinger, E. Horwitz, W. Leung, 2007, Pediatric blood & cancer.

Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors.

J. Wingard, J. Liesveld, T. Spitzer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant Patients

D. Srivastava, Z. Gu, R. Handgretinger, 2006, Transplantation.

Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002.

D. Srivastava, R. Handgretinger, E. Horwitz, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Profile Differences between Chronic GvHD and Late Acute GvHD: Results of the ABLE/PBMTC 1202 Studies.

S. Mostafavi, J. Chewning, G. Cuvelier, 2020, Blood.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

M. Norkin, W. Wood, J. Wingard, 2015, Bone Marrow Transplantation.

A Prospective Cohort Study of Late Sequelae of Pediatric Allogeneic Hematopoietic Stem Cell Transplantation

C. Pui, S. R. Rose, S. Phipps, 2007, Medicine.

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

J. Tisdale, L. Krishnamurti, A. Thompson, 2021, New England Journal of Medicine.

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.

V. Brown, R. Egeler, M. Cairo, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia.

S. Davies, P. Mehta, M. Ayas, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Airway Evaluation and Management in 7 Children With Malignant Infantile Osteopetrosis Before Hematopoietic Stem Cell Transplantation

S. Kaste, E. Horwitz, K. Kasow, 2008, Journal of pediatric hematology/oncology.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Effie W Petersdorf, John Horan, Michelle Setterholm, 2010, Blood.

Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.

S. Davies, P. Mehta, M. Cairo, 2014, Blood.

K. Leung, M. Horowitz, J. Panepinto, 2016, Blood.

Haploidentical transplants Effective donor lymphohematopoietic reconstitution after haploidentical CD34 þ -selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia

J. Cunningham, Winfred C. Wang, R. Handgretinger, 2004 .

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

E. Neufeld, F. Trachtenberg, A. Thompson, 2013 .

Mismatched Family Member Donor Transplantation for Patients with Refractory Hematologic Malignancies: Long-Term Followup of a Prospective Clinical Trial.

R. Handgretinger, E. Horwitz, W. Leung, 2006 .

Haploidentical Stem Cell Transplantation with CD3 Depleted Mobilized Peripheral Blood Stem Cell Grafts for Children with Hematologic Malignancies.

D. Srivastava, R. Handgretinger, E. Horwitz, 2005 .

Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation.

J. Panetta, S. Baker, R. Handgretinger, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms’ Tumor: A CIBMTR retrospective analysis

R. Gale, M. Thakar, Michael T. Hemmer, 2017, Bone Marrow Transplantation.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

CD3 Depleted Hematopoietic Peripheral Blood Stem Cell Grafts in Children with Refractory Hematologic Malignancies Undergoing Transplantation from Mismatched Related Donors.

D. Srivastava, R. Handgretinger, E. Horwitz, 2005 .

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders.

M. Pulsipher, K. Chan, G. Hale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

M. Norkin, J. Szer, J. Liesveld, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

M. Norkin, J. Liesveld, Z. DeFilipp, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

P. Hari, W. Tse, M. Horowitz, 2018, Haematologica.

Clinical Outcomes of Patients with Desmoplastic Small Round Cell Tumor of the Peritoneum Undergoing Autologous HCT: a CIBMTR Retrospective Analysis

N. Ueno, M. Bishop, H. Lazarus, 2012, Bone Marrow Transplantation.

A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.

T. Merchant, R. Gilbertson, R. Krance, 2009, Neuro-oncology.

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study

J. Chewning, G. Cuvelier, B. Ng, 2022, Blood advances.

Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

J. Chewning, G. Cuvelier, A. Kariminia, 2021, Blood.

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma

W. Wood, Z. DeFilipp, B. Shaw, 2018, Cancer.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

J. Liesveld, Z. DeFilipp, B. Shaw, 2020, Blood advances.

Rabbit anti-thymocyte globulin (rATG;thymoglobulin®) pharmacokinetics in pediatric patients receiving a hematopoietic stem cell transplant (HSCT)

R. Handgretinger, E. Horwitz, J. Rodman, 2006 .

Improving Quality Manager (QM) Workload Management in Order to Increase Their Resiliency and Effectiveness in Contributing to Program Success

K. Kasow, J. W. Atkins, Karen Collum, 2019, Biology of Blood and Marrow Transplantation.

Increasing Work Resilience of the Quality Manager (QM) in Order to Improve Their Effectiveness in Contributing to Program Success

K. Kasow, Karen Collum, T. Dodd, 2018 .

Outcomes of pediatric patients with therapy-related myeloid neoplasms

Cheng Cheng, K. Somers, P. Amrolia, 2021, Bone Marrow Transplantation.

Long-term organ function after HCT for SCD: a report from the Sickle cell Transplant Advocacy and Research alliance.

Yijin Xiang, L. Krishnamurti, J. Kanter, 2022, Transplantation and cellular therapy.

Children's Mercy Kansas City

B. George, V. Mathews, C. Dvorak, 2020 .

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

M. Aljurf, L. Diller, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.

D. Srivastava, R. Handgretinger, E. Horwitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Resolution of Serious Vaso-Occlusive Pain Crises and Reduction in Patient-Reported Pain Intensity: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy

J. Tisdale, M. Gallagher, Manfred Schmidt, 2020 .

Pediatric Hematologist/Oncologists' Beliefs about Hematopoietic Stem Cell Transplant for Children with Sickle Cell Disease: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) Study

K. Kasow, G. Guilcher, E. Meier, 2019, Blood.

Current and Future Cell Therapy Standards and Guidelines.

K. Kasow, J. W. Atkins, K. West, 2019, Hematology/oncology clinics of North America.

Through the eyes of young sibling donors: the hematopoietic stem cell donation experience.

J. D'Auria, K. Kasow, T. Fitzgerald, 2015, Journal of pediatric nursing.

Sequential renal and bone marrow transplants in a child with Fanconi anemia

K. Kasow, W. Primack, John Hipps, 2016, Pediatric transplantation.

This information is current as Counterparts − CD 25 + Repertoires with CD 4 Share Equally Complex and Comparable Regulatory T Cells + CD 25 + Human CD 4

J. Riberdy, K. Kasow, Xiaohua Chen, 2004 .

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.

T. Merchant, M. Chintagumpala, A. Gajjar, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation.

A. Srinivasan, D. Srivastava, J. Panetta, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequential renal and bone marrow transplants in a child with Fanconi anemia

K. Kasow, W. Primack, John Hipps, 2016, Pediatric transplantation.

Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis

J. Cunningham, R. Handgretinger, E. Horwitz, 2004, Bone Marrow Transplantation.

Financial burden and recommended multilevel solutions among caregivers of pediatric hematopoietic stem cell transplant recipients

Austin Waters, K. Kasow, Lisa P. Spees, 2023, Pediatric blood & cancer.